What is the equity of Pharmaron Beijing Co this year?
Pharmaron Beijing Co has equity of 12.56 B CNY this year.
Pharmaron Beijing Co Equity 2024
Pharmaron Beijing Co Equity
12.56 B CNY
Ticker
300759.SZ
ISIN
CNE100003JW4
In 2024, Pharmaron Beijing Co's equity was 12.56 B CNY, a 19.04% increase from the 10.55 B CNY equity in the previous year.
Pharmaron Beijing Co Aktienanalyse
What does Pharmaron Beijing Co do?
Pharmaron Beijing Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Pharmaron Beijing Co's Equity
Pharmaron Beijing Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Pharmaron Beijing Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Pharmaron Beijing Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Pharmaron Beijing Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Pharmaron Beijing Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Pharmaron Beijing Co stock
What was the equity of Pharmaron Beijing Co compared to the previous year?
The equity of Pharmaron Beijing Co has increased/decreased by 19.04% increased compared to the previous year.
What impact does a high equity have on investors of Pharmaron Beijing Co?
A high equity is advantageous for investors of Pharmaron Beijing Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Pharmaron Beijing Co?
A low equity can be a risk for investors of Pharmaron Beijing Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Pharmaron Beijing Co affect the company?
An increase in equity of Pharmaron Beijing Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Pharmaron Beijing Co affect the company?
A reduction in equity of Pharmaron Beijing Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Pharmaron Beijing Co?
Some factors that can affect the equity of Pharmaron Beijing Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Pharmaron Beijing Co so important for investors?
The equity of Pharmaron Beijing Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Pharmaron Beijing Co take to change the equity?
To change equity, Pharmaron Beijing Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Pharmaron Beijing Co pay?
Over the past 12 months, Pharmaron Beijing Co paid a dividend of 0.2 CNY . This corresponds to a dividend yield of about 0.66 %. For the coming 12 months, Pharmaron Beijing Co is expected to pay a dividend of 0.22 CNY.
What is the dividend yield of Pharmaron Beijing Co?
The current dividend yield of Pharmaron Beijing Co is 0.66 %.
When does Pharmaron Beijing Co pay dividends?
Pharmaron Beijing Co pays a quarterly dividend. This is distributed in the months of July, July, August, July.
How secure is the dividend of Pharmaron Beijing Co?
Pharmaron Beijing Co paid dividends every year for the past 8 years.
What is the dividend of Pharmaron Beijing Co?
For the upcoming 12 months, dividends amounting to 0.22 CNY are expected. This corresponds to a dividend yield of 0.73 %.
In which sector is Pharmaron Beijing Co located?
Pharmaron Beijing Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pharmaron Beijing Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pharmaron Beijing Co from 6/27/2024 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.
When did Pharmaron Beijing Co pay the last dividend?
The last dividend was paid out on 6/27/2024.
What was the dividend of Pharmaron Beijing Co in the year 2023?
In the year 2023, Pharmaron Beijing Co distributed 0.2 CNY as dividends.
In which currency does Pharmaron Beijing Co pay out the dividend?
The dividends of Pharmaron Beijing Co are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Pharmaron Beijing Co
Our stock analysis for Pharmaron Beijing Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharmaron Beijing Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Pharmaron Beijing Co Revenue
- Pharmaron Beijing Co Net Income
- Pharmaron Beijing Co P/E
- Pharmaron Beijing Co P/S
- Pharmaron Beijing Co EBIT
- Pharmaron Beijing Co Dividend
- Pharmaron Beijing Co Stocks
- Pharmaron Beijing Co Market capitalization
- Pharmaron Beijing Co Debt
- Pharmaron Beijing Co Liabilities
- Pharmaron Beijing Co Equity
- Pharmaron Beijing Co AAQS
- Pharmaron Beijing Co Employees
- Pharmaron Beijing Co ROE
- Pharmaron Beijing Co ROA
- Pharmaron Beijing Co ROCE